114 related articles for article (PubMed ID: 36396062)
41. Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients.
Mancini BR; Park HS; Harder EM; Rutter CE; Corso CD; Decker RH; Husain ZA
Lung Cancer; 2016 Jul; 97():22-7. PubMed ID: 27237023
[TBL] [Abstract][Full Text] [Related]
42. Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram.
Ayala-Peacock DN; Attia A; Braunstein SE; Ahluwalia MS; Hepel J; Chung C; Contessa J; McTyre E; Peiffer AM; Lucas JT; Isom S; Pajewski NM; Kotecha R; Stavas MJ; Page BR; Kleinberg L; Shen C; Taylor RB; Onyeuku NE; Hyde AT; Gorovets D; Chao ST; Corso C; Ruiz J; Watabe K; Tatter SB; Zadeh G; Chiang VLS; Fiveash JB; Chan MD
J Neurooncol; 2017 Nov; 135(2):403-411. PubMed ID: 28828698
[TBL] [Abstract][Full Text] [Related]
43. Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
Jacobs CD; Mehta K; Gao J; Wang X; Salama JK; Kelsey CR; Torok JA
Clin Lung Cancer; 2022 Mar; 23(2):177-184. PubMed ID: 34301453
[TBL] [Abstract][Full Text] [Related]
44. Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).
Nikitas J; Roach M; Robinson C; Bradley J; Huang J; Perkins S; Tsien C; Abraham C
Clin Transl Radiat Oncol; 2020 Mar; 21():32-35. PubMed ID: 31956701
[TBL] [Abstract][Full Text] [Related]
45. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
Burdick MJ; Stephans KL; Reddy CA; Djemil T; Srinivas SM; Videtic GM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1033-9. PubMed ID: 20472359
[TBL] [Abstract][Full Text] [Related]
46. Comparison of Single- and Three-fraction Schedules of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-Small-cell Lung Cancer.
Ma SJ; Serra LM; Syed YA; Hermann GM; Gomez-Suescun JA; Singh AK
Clin Lung Cancer; 2018 Mar; 19(2):e235-e240. PubMed ID: 29153897
[TBL] [Abstract][Full Text] [Related]
47. Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer.
McLaughlin MF; Alam M; Smith L; Ryckman J; Lin C; Baine MJ
PLoS One; 2020; 15(11):e0241505. PubMed ID: 33253196
[TBL] [Abstract][Full Text] [Related]
48. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
[TBL] [Abstract][Full Text] [Related]
49. Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis-4N0M0 Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy.
Nemoto T; Takeda A; Matsuo Y; Kishi N; Eriguchi T; Kunieda E; Kimura R; Sanuki N; Tsurugai Y; Yagi M; Aoki Y; Oku Y; Kimura Y; Han C; Shigematsu N
JCO Clin Cancer Inform; 2022 Jun; 6():e2100176. PubMed ID: 35749675
[TBL] [Abstract][Full Text] [Related]
50. Development and Validation of a CT-Based Signature for the Prediction of Distant Metastasis Before Treatment of Non-Small Cell Lung Cancer.
Tao J; Lv R; Liang C; Fang J; Liu D; Lan X; Huang H; Zhang J
Acad Radiol; 2022 Feb; 29 Suppl 2():S62-S72. PubMed ID: 33402298
[TBL] [Abstract][Full Text] [Related]
51. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
[TBL] [Abstract][Full Text] [Related]
52. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
Pyka T; Bundschuh RA; Andratschke N; Mayer B; Specht HM; Papp L; Zsótér N; Essler M
Radiat Oncol; 2015 Apr; 10():100. PubMed ID: 25900186
[TBL] [Abstract][Full Text] [Related]
53. Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
Schonewolf CA; Heskel M; Doucette A; Singhal S; Frick MA; Xanthopoulos EP; Corradetti MN; Friedberg JS; Pechet TT; Christodouleas JP; Levin W; Berman A; Cengel KA; Verma V; Hahn SM; Kucharczuk JC; Rengan R; Simone CB
Clin Lung Cancer; 2019 Jan; 20(1):e63-e71. PubMed ID: 30337269
[TBL] [Abstract][Full Text] [Related]
54. The prognostic risk stratification model for metastatic small-cell lung cancer: An analysis of the SEER database.
Qie S; Shi H; Wang F; Liu F; Zhang X; Li Y; Sun X
Medicine (Baltimore); 2022 Oct; 101(42):e31000. PubMed ID: 36281112
[TBL] [Abstract][Full Text] [Related]
55. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.
Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS
Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630
[TBL] [Abstract][Full Text] [Related]
56. The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy.
Ernani V; Appiah AK; Baine MJ; Smith LM; Ganti AK
Cancer Treat Res Commun; 2020; 24():100197. PubMed ID: 32777751
[TBL] [Abstract][Full Text] [Related]
57. A Prediction Model to Help with Oncologic Mediastinal Evaluation for Radiation: HOMER.
Martinez-Zayas G; Almeida FA; Simoff MJ; Yarmus L; Molina S; Young B; Feller-Kopman D; Sagar AS; Gildea T; Debiane LG; Grosu HB; Casal RF; Arain MH; Eapen GA; Jimenez CA; Noor LZ; Baghaie S; Song J; Li L; Ost DE
Am J Respir Crit Care Med; 2020 Jan; 201(2):212-223. PubMed ID: 31574238
[No Abstract] [Full Text] [Related]
58. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
[TBL] [Abstract][Full Text] [Related]
59. Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs.
Syed YA; Stokes W; Rupji M; Liu Y; Khullar O; Sebastian N; Higgins K; Bradley JD; Curran WJ; Ramalingam S; Taylor J; Sancheti M; Fernandez F; Moghanaki D
Chest; 2022 Mar; 161(3):833-844. PubMed ID: 34785235
[TBL] [Abstract][Full Text] [Related]
60. Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy.
Shaverdian N; Veruttipong D; Wang J; Kupelian P; Steinberg M; Lee P
J Thorac Oncol; 2016 Aug; 11(8):1319-1325. PubMed ID: 27234604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
